Clinical Trial Update: MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This clinical trial update indicates the Phase III insulin add-on study of MK-0431/ONO-5435 for Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0431/ONO-5435

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED